Le Lézard
Classified in: Health
Subjects: SVY, SCZ

Doctors Making Housecalls Saves Assisted Living Corporation Millions Via Onsite, Proactive Primary Care



DURHAM, N.C., Aug. 27, 2019 /PRNewswire/ --

DMHC Assisted Living stats:

Between January 2017 and July 2019, 236 assisted living residents under the care of DMHC clinicians remained in their communities an average of 6 months longer than 7,863 residents whose healthcare was provided by other clinicians.  Data were obtained from a large assisted living corporation headquartered in North Carolina.

For the DMHC residents, the value of 6 additional months of quality life is immeasurable. Unnecessary transfers to nursing homes is often avoided. For the assisted living corporation, the cost savings solely for this group of residents is estimated at nearly $5 million.

DMHC achieves these superior outcomes for assisted living residents and their communities through proactive, onsite healthcare.  Its accomplishments have been well-documented by the Centers for Medicare and Medicaid Services (CMS) based on its participation in a 7-year, national research study (The Independence at Home Demonstration) in which DMHC consistently outperforms all CMS quality-of-care benchmarks.

DMHC is currently seeking to partner with additional assisted living corporations as a preferred provider of onsite primary care services.

About Doctors Making Housecalls

Doctors Making Housecalls (DMHC) is the largest geriatric medical practice in the U.S. southeast.  It has repeatedly been honored by CMS as a leader in achieving exceptional healthcare outcomes for the medically complex and high-risk residents living in nearly 400 North Carolina assisted living communities.

Name:  Dr. Alan Kronhaus, Co-founder and CEO

e-mail:  akronhaus@doctorsmakinghousecalls.com

Name:  Dr. Shohreh Taavoni, Co-founder and CMO

e-mail:  staavoni@doctorsmakinghousecalls.com

Name:  Dr. Steven Fuller, Executive Vice President

e-mail:  sfuller@doctorsmakinghousecalls.com

 

SOURCE Doctors Making Housecalls


These press releases may also interest you

at 18:20
bluebird bio, Inc. and Bristol-Myers Squibb announced updated safety and efficacy results from the ongoing Phase 1 study (CRB-402) of bb21217, an investigational BCMA-targeted chimeric antigen receptor (CAR) T cell therapy being studied in patients...

at 18:20
Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan, today presented topline data from the ASCERTAIN phase 3 trial of the orally administered fixed dose combination of cedazuridine and...

at 17:50
Amphivena Therapeutics, Inc., a private clinical stage immuno-oncology company developing T cell engager therapeutics for cancer, presented today at the American Society of Hematology annual meeting data from a Phase 1 study of its bivalent T cell...

at 17:40
Welltower Inc. announces that on December 24, 2019, it is redeeming all of the outstanding 3.35% Senior Notes due November 25, 2020 (the "Notes") issued by HCN Canadian Holdings-1 LP, its wholly-owned subsidiary, in accordance with the terms of the...

at 17:20
Quest Diagnostics Incorporated , the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal amount of its 2.950% senior notes due 2030 under the Quest...

at 17:20
Bariatric Surgery Devices (General Surgery) - Global Market Analysis and Forecast Model Read the full report: https://www.reportlinker.com/p05830908/?utm_source=PRN Summary Bariatric Surgery Devices (General Surgery) - Global Market Analysis and...



News published on 27 august 2019 at 06:00 and distributed by: